Market Overview

Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Share:
Related VRX
What's The FDA Saying About Valeant's Manufacturing Facility Issues?
Valeant's CEO Details The Company's 'Great Progress' And What's Next
Related GLW
5 Biggest Price Target Changes For Tuesday
Benzinga's Top Upgrades, Downgrades For August 15, 2017

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc (NYSE: VRX). He thinks the company should do an equity offering to reduce its huge debt. There is still a large short position in the stock and some investors decided to cover it, because the downside is now quantified. He doesn't see Valeant as a good long position.

Cramer thinks Corning Incorporated (NYSE: GLW) is having a good run and the stock is a buy.

Cramer can't recommend Synergy Pharmaceuticals Inc (NASDAQ: SGYP) for anything other than a speculation. It's still in an early stage and it didn't report a good quarter.

Posted-In: Mad MoneyCNBC Jim Cramer Media

 

Related Articles (GLW + SGYP)

View Comments and Join the Discussion!